161 related articles for article (PubMed ID: 8599100)
1. Misfolding the way to disease.
Taubes G
Science; 1996 Mar; 271(5255):1493-5. PubMed ID: 8599100
[No Abstract] [Full Text] [Related]
2. Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses.
Gajdusek DC
Mol Neurobiol; 1994 Feb; 8(1):1-13. PubMed ID: 8086124
[TBL] [Abstract][Full Text] [Related]
3. Amyloidosis in Alzheimer's disease.
Allsop D; Williams CH
Biochem Soc Trans; 1994 Feb; 22(1):171-5. PubMed ID: 8206218
[No Abstract] [Full Text] [Related]
4. Medicine. Prion-like behavior of amyloid-beta.
Kim J; Holtzman DM
Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
[No Abstract] [Full Text] [Related]
5. Prion-like aggregates: infectious agents in human disease.
Westermark GT; Westermark P
Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-beta: a (life) preserver for the brain.
Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA
Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809
[No Abstract] [Full Text] [Related]
7. Alzheimer's disease and the amyloid β-protein.
Walsh DM; Teplow DB
Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
[TBL] [Abstract][Full Text] [Related]
8. Human brain amyloidoses.
Gambetti P; Russo C
Nephrol Dial Transplant; 1998; 13 Suppl 7():33-40. PubMed ID: 9870435
[No Abstract] [Full Text] [Related]
9. Testing times for the "amyloid cascade hypothesis".
Hardy J
Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803
[No Abstract] [Full Text] [Related]
10. Alternative conformations of amyloidogenic proteins govern their behavior.
Kelly JW
Curr Opin Struct Biol; 1996 Feb; 6(1):11-7. PubMed ID: 8696966
[TBL] [Abstract][Full Text] [Related]
11. Bioflocculant hypothesis: a partial endorsement.
Terry R
Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804
[No Abstract] [Full Text] [Related]
12. Evolution and the scientific method.
Tucker HM; Estus S
Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808
[No Abstract] [Full Text] [Related]
13. Unifying features of systemic and cerebral amyloidosis.
Ghiso J; Wisniewski T; Frangione B
Mol Neurobiol; 1994 Feb; 8(1):49-64. PubMed ID: 7916192
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
Price DL; Borchelt DR; Sisodia SS
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
[TBL] [Abstract][Full Text] [Related]
15. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
16. [Molecular neurobiology of Alzheimer amyloid protein precursor].
Yoshikawa K
Seikagaku; 1993 Sep; 65(9):1149-59. PubMed ID: 8270816
[No Abstract] [Full Text] [Related]
17. Hidden amyloidoses.
Diringer H
Exp Clin Immunogenet; 1992; 9(4):212-29. PubMed ID: 1364008
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches.
Soto C
J Mol Med (Berl); 1999 May; 77(5):412-8. PubMed ID: 10426190
[TBL] [Abstract][Full Text] [Related]
20. Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins.
Janssen L; Keppens C; De Deyn PP; Van Dam D
Biochim Biophys Acta; 2016 Jan; 1862(1):105-12. PubMed ID: 26542217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
